Aortic vascular graft infection caused by Cardiobacterium valvarum: A case report

Journal of Infection and Chemotherapy

Volumn 20, Issue 12, 2014, Pages 804-809

  Hagiya, Hideharu ^a   Kokeguchi, Susumu ^a   Ogawa, Hiroko ^a   Terasaka, Tomohiro ^a   Kimura, Kosuke ^a   Waseda, Koichi ^a   Hanayama, Yoshihisa ^a   Oda, Kaori ^a   Mori, Hisatoshi ^a   Miyoshi, Toru ^a   Otsuka, Fumio ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Aortic vascular graft; Cardiobacterium; Hyperglobulinemia; Infective aneurysm; Infective endocarditis; Septic embolism

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CARVEDILOL; CEFTRIAXONE; FEBUXOSTAT; LEVOFLOXACIN; NIFEDIPINE; RNA 16S; TELMISARTAN; ANTIINFECTIVE AGENT;

ADULT; ANOREXIA; ANTIBIOTIC THERAPY; AORTA DISSECTION; AORTA GRAFT; AORTA VALVE REGURGITATION; AORTIC VASCULAR GRAFT INFECTION; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; BLOOD VESSEL GRAFT; BODY WEIGHT; CARDIOBACTERIUM; CARDIOBACTERIUM VALVARUM; CASE REPORT; DISEASE COURSE; DRUG WITHDRAWAL; GINGIVA HYPERPLASIA; GOUT; GRAFT INFECTION; HUMAN; HYPERTENSION; MALAISE; MALE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; NIGHT SWEAT; PROSTHETIC VASCULAR GRAFT INFECTION; PROTEIN BLOOD LEVEL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; WEIGHT REDUCTION; BLOOD VESSEL PROSTHESIS; GRAM NEGATIVE INFECTION; INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; PERIODONTITIS; SURGERY; THORACIC AORTA;

ANTI-BACTERIAL AGENTS; AORTA, THORACIC; BLOOD VESSEL PROSTHESIS; CARDIOBACTERIUM; ENDOCARDITIS, BACTERIAL; GINGIVAL HYPERPLASIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PERIODONTITIS; PROSTHESIS-RELATED INFECTIONS;

EID: 84939218380     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2014.07.008     Document Type: Article

References (27)

1. Berbari EF, Cockerill FR, Steckelberg JM. Infective endocarditis due to unusual or fastidious microorganisms. Mayo Clin Proc 1997;72:532-42.
2. Chambers ST, Murdoch D, Morris A, Holland D, Pappas P, Almela M, et al. HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort. PLoS One 2013;8:e63181.
3. Selton-Suty C, Celard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 2012;54:1230-9.
4. Ferreiros E, Nacinovich F, Casabe JH, Modenesi JC, Swieszkowski S, Cortes C, et al. Epidemiologic, clinical, and microbiologic profile of infective endocarditis in Argentina: a national survey. The Endocarditis Infecciosa en la Republica Argentina-2 (EIRA-2) Study. Am Heart J 2006;151:545-52.
5. Tleyjeh IM, Steckelberg JM, Murad HS, Anavekar NS, Ghomrawi HM, Mirzoyev Z, et al. Temporal trends in infective endocarditis: a populationbased study in Olmsted County, Minnesota. JAMA 2005;293:3022-8.
6. Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 2001;14:177-207.
7. Slotnick IJ, Dougherty M. Further characterization of an unclassified group of bacteria causing endocarditis in man: Cardiobacterium hominis Gen. Et Sp. N. Antonie Van Leeuwenhoek 1964;30:261-72.
8. Han XY, Meltzer MC, Woods JT, Fainstein V. Endocarditis with ruptured cerebral aneurysm caused by Cardiobacterium valvarum sp. nov. J Clin Microbiol 2004;42:1590-5.
9. Hoover SE, Fischer SH, Shaffer R, Steinberg BM, Lucey DR. Endocarditis due to a novel Cardiobacterium species. Ann Intern Med 2005;142:229-30.
10. Bothelo E, Gouriet F, Fournier PE, Roux V, Habib G, Thuny F, et al. Endocarditis caused by Cardiobacterium valvarum. J Clin Microbiol 2006;44:657-8.
11. Geissdorfer W, Tandler R, Schlundt C, Weyand M, Daniel WG, Schoerner C. Fatal bioprosthetic aortic valve endocarditis due to Cardiobacterium valvarum. J Clin Microbiol 2007;45:2324-6.
12. Gonzalez JB, Woc-Colburn L, Schreckenberger PC, Malow JB. Bicuspid aortic valve endocarditis due to cardiobacterium valvarum: case report and review of literature. Infect Dis Clin Pract 2007;15:364-7. http://dx.doi.org/10.1097/IPC.0b013-3181342f74.
13. Hoffman MJ, Macrie BD, Taiwo BO, Qi C. Prosthetic valve/conduit infection caused by Cardiobacterium valvarum. Infection 2010;38:245-6.
14. Vanerkova M, Zaloudikova B, Nemcova E, Jurankova J, Pol J, Cerny J, et al. Detection of Cardiobacterium valvarum in a patient with aortic valve infective endocarditis by broad-range PCR. J Med Microbiol 2010;59:231-4.
15. Chen M, Kemp M, Bruun NE, Bangsborg JM, Hojlyng N, Hesselbjerg A, et al. Cardiobacterium valvarum infective endocarditis and phenotypic/molecular characterization of 11 Cardiobacterium species strains. J Med Microbiol 2011;60:522-8.
16. Abraham R, Irwin RB, Kannappan D, Isalska B, Koroma M, Younis N. Cerebral vasculitis and Cardiobacterium valvarum endocarditis. J Med Microbiol 2012;61:1625-30.
17. Choudhury S, Isais FS, Lee CC. Nonsurgical management of mitral valve endocarditis due to Cardiobacterium valvarum in a patient with a ventricular septal defect. J Clin Microbiol 2013;51:1996-7.
18. Ashimoto A, Chen C, Bakker I, Slots J. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 1996;11:266-73.
19. Han XY, Falsen E. Characterization of oral strains of Cardiobacterium valvarum and emended description of the organism. J Clin Microbiol 2005;43:2370-4.
20. Clarridge 3rd JE. Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev 2004;17:840-62 [table of contents].
21. Wallet F, Loiez C, Decoene C, Courcol R. Rapid identification of Cardiobacterium hominis by MALDI-TOF mass spectrometry during infective endocarditis. Jpn J Infect Dis 2011;64:327-9.
22. Fedak PW, Verma S, David TE, Leask RL, Weisel RD, Butany J. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation 2002;106:900-4.
23. Ward C. Clinical significance of the bicuspid aortic valve. Heart 2000;83:81-5.
24. Kugler KC, Biedenbach DJ, Jones RN. Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms. Diagn Microbiol Infect Dis 1999;34:73-6.
25. Citron DM, Warren YA, Fernandez HT, Goldstein MA, Tyrrell KL, Goldstein EJ. Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens. J Clin Microbiol 2005;43:2485-8.
26. Prisant LM, Herman W. Calcium channel blocker induced gingival overgrowth. J Clin Hypertens (Greenwich) 2002;4:310-1.
27. Samarasinghe YP, Cox A, Feher MD. Calcium channel blocker induced gum hypertrophy: no class distinction. Heart 2004;90:16.